Current Opinion in Organ Transplantation was launched in 1996. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of organ transplantation is divided into 18 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Editor-in-Chief, Associate Editors and Section Editors for this issue.
Linda S. Sher
Dr Sher is Associate Professor of Clinical Surgery and Director of Clinical Research in the Division of Hepatobiliary Surgery and Abdominal Organ Transplantation at Keck School of Medicine, University of Southern California (USC), USA. After completing her medical school education and surgical residency at Mount Sinai School of Medicine in New York, USA, Dr Sher undertook her fellowship training in Liver and Kidney Transplantation at the University of Pittsburgh, USA. After completing her fellowship in 1988, Dr Sher was involved in the establishment of two liver transplant programs in Los Angeles prior to joining the USC program in 2001. Dr Sher has participated in and overseen over 50 research projects and is currently very active in the development of the clinical and basic science research components of the USC Abdominal Organ Transplantation Program. She has numerous publications on immunosuppression, chronic rejection, disease recurrence, infection, prophylaxis and hepatobiliary surgery.
Dr Sher is one of the original editors of Current Opinion in Organ Transplantation and has endeavored over the years to provide the reader with an up to date overview of the entire field of organ transplantation.
Josep M. Grinyó
Josep M. Grinyó, MD, PhD, is the Chief of Nephrology at the University Hospital of Bellvitge, Spain, and Full Professor of Medicine at the University of Barcelona, Department of Medicine, Spain. Dr Grinyó's research work on renal transplantation has been focused on immunosuppression, ischemia-reperfusion injury and chronic allograft damage in the clinical setting and in experimental animal models.
Josep M. Grinyó is Associate Editor of the Current Opinion in Transplantation, Transplant International, Consulting Editor of the American Journal of Transplantation and member of the editorial boards of Transplantation and Kidney International.
Josep M. Grinyó has authored or coauthored over 300 articles and given more than 200 invited lectures.
Jerzy W. Kupiec-Weglinski
Dr Kupiec-Weglinski graduated from Warsaw Medical Academy, Poland, in 1974, and received his Ph.D. at the Polish Academy of Sciences. In 1979 he joined the Transplant Research Laboratories, Brigham and Women's Hospital at Harvard Medical School in Boston, MA, USA. Since 1997, Dr Kupiec-Weglinski has been the Director of Dumont- University of California, Los Angeles (UCLA) Transplant Research Laboratories in Los Angeles, USA. He is Professor of Surgery and Pathology, and Vice-Chairman, Department of Surgery (Research), at the David Geffen School of Medicine at UCLA, USA. He holds the Joan S. and Ralph N. Goldwyn Endowed Chair in Transplantation Research. Dr Kupiec-Weglinski's interests focus on the immunobiology of organ ischemia and reperfusion injury, host sensitization, and tolerance induction. He has authored over 400 papers. He is Associate Editor of Current Opinion in Organ Transplantation and serves as a member of the editorial board of Transplantation, Liver Transplantation, Transplantation Immunology, Annals of Transplantation, among others. His research for the last 25 years has been funded by National Institute of Health (NIH) and he is currently a standing member of the Transplantation, Tolerance and Tumor Immunology (TTT) NIH Study Section. Dr Kupiec-Weglinski is a past member of the board of directors of American Society of Transplantation, and recipient of AST/Astellas Established Investigator Award in Basic Transplant Research. He holds the Honorary Doctorate (“Honoris Causa”) from Medical Academy in Warsaw, and is the Foreign Member of Polish Academy of Sciences.
Giuseppe Remuzzi, M.D. – Bergamo, Italy. Actually Professor of Nephrology, Director of the Department of Medicine of the Ospedali Riuniti di Bergamo (Papa Giovanni XXIII Hospital), Italy and Director of the Division of Nephrology and Dialysis of the same hospital. He also directs the Negri Bergamo Laboratories of the “Mario Negri” Institute for Pharmacological Research, a group of basic scientists and clinicians devoted to the study of human renal diseases and their corresponding animal models from the perspective of pathophysiology and therapeutic intervention. He touched major advances in many areas of nephrology. For example, his studies have led to new insights into many disorders, including the interactions between platelets and endothelium, pathophysiology of glomerular diseases and the factors that influence the progressive loss of kidney function. Work focused on improving the outlook for patients with end stage renal disease. Giuseppe Remuzzi pays tribute to the work of pioneers such as Barry Brenner, who delved deep into the processes behind glomerular function and their possible reversibility. Early work on the use of angiotensin-converting enzyme inhibitors to slow the decline of glomerular filtration rates proved dialysis was avoidable, not inevitable. Studies on immunologic mechanisms that influence the survival of transplanted organs, understanding of immunologic tolerance in the disorders that are linked to autoimmunity and finally, genetic diseases of the kidney have also been areas of investigation. Concerned by kidney donation shortages and deploring the current practice of discarding suboptimal donor kidneys, his team has shown that transplanting such kidneys in pairs is feasible and have set up an international effort to validate this approach. Giuseppe Remuzzi is investigating the kidney's ability to regenerate itself.
He authored and co-authored more than 1249 scientific articles, reviews and monographs and serves on editorial boards of numerous journals, he is member of the International Advisory Board of The Lancet and was an Editorial Board member of the New England Journal of Medicine from 1995–2013. During his professional career he received the International Society of Nephrology (ISN) Jean Hamburger Award (World Congress of Nephrology (WCN) 2005, Singapore), the John P. Peters Award (American Society of Nephrology (ASN) 2007, San Francisco) and the ISN AMGEN Award (WCN 2011, Vancouver). In November 2011, he won the Third Edition of the International Award “Luis Hernando” assigned by the Iñigo Alvarez de Toledo Renal Foundation (FRIAT) in Madrid, Spain. He is, since June 2013, President of the International Society of Nephrology (ISN) for the period 2013–2015. Prof. Remuzzi is an advocate of the ISN human rights initiative called ‘0 by 25’ - in which ISN strives for a situation in which nobody in emerging countries should die of preventable and treatable acute kidney injury (AKI) by 2025.
Jonathan A. Fridell
Dr Jonathan A. Fridell completed his medical degree and surgical residency training at McGill University, Montreal, Canada and abdominal transplant fellowship at the University of Pittsburgh Medical Center, USA. Dr Fridell is board certified in General Surgery in the United States and Canada and is a Fellow of the American College of Surgeons and a Fellow of the Royal College of Surgeons of Canada. On the faculty at Indiana University, USA, since July, 2002, Dr Fridell specializes in pancreas, liver, kidney, intestinal and multivisceral transplantation. He is a Professor of Surgery and the Director of the Pancreas Transplant Program. After serving several years as the regional representative to the United Network of Organ Sharing (UNOS) Kidney Transplant and Pancreas Transplant Committees, he is currently the Chair of the UNOS Pancreas Transplant Committee. He is the Deputy Editor for Pancreas and Islet Cell Transplantation for the journal Clinical Transplantation and is on the editorial board for the journal Transplantation. He has written extensively on the topic of pancreas transplantation and has received recognition for his work with awards including the Patient's Choice Award (2008-present), America's Leading Experts (2009), Most Compassionate Doctor Award (2010), America's Top Surgeons (2010) and Indianapolis Monthly's Top Doctors (2013-present).